NCAM1 and schizophrenia: In the hippocampus of patients with schizophrenia, PSA-NCAM immunoreactivity is reduced, and there are more embryonic structures of NCAM, indicating that the plasticity of NCAM in the brain has changed, which further affects neurodevelopment [28].